Education
About Us
Working with TipRanks
Follow Us
Third Harmonic Bio, Inc. (THRD)
NASDAQ:THRD
RESEARCH TOOLSreports
Total Valuation
Third Harmonic Bio, Inc. has a market cap or net worth of $238.73M. The enterprise value is ―.
Market Cap$238.73M
Enterprise Value―
Share Statistics
Third Harmonic Bio, Inc. has 45,127,796 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding45,127,796
Owned by Insiders37.63%
Owned by Institutions<0.01%
Financial Efficiency
Third Harmonic Bio, Inc.’s return on equity (ROE) is 0.16 and return on invested capital (ROIC) is 20.42%.
Return on Equity (ROE)0.16
Return on Assets (ROA)0.15
Return on Invested Capital (ROIC)20.42%
Return on Capital Employed (ROCE)0.20
Revenue Per Employee0.00
Profits Per Employee-1.47M
Employee Count31
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Third Harmonic Bio, Inc. is 9.44. Third Harmonic Bio, Inc.’s PEG ratio is -0.06.
PE Ratio9.44
PS Ratio0.00
PB Ratio0.50
Price to Fair Value1.51
Price to FCF-4.59
Price to Operating Cash Flow-4.14
PEG Ratio-0.06
Income Statement
In the last 12 months, Third Harmonic Bio, Inc. had revenue of 0.00 and earned 45.47M in profits. Earnings per share was 1.09.
Revenue0.00
Gross Profit0.00
Operating Income58.87M
Pretax Income45.47M
Net Income45.47M
EBITDA58.87M
Earnings Per Share (EPS)1.09
Cash Flow
In the last 12 months, operating cash flow was -34.50M and capital expenditures -10.00K, giving a free cash flow of -34.51M billion.
Operating Cash Flow-34.50M
Free Cash Flow-34.51M
Free Cash Flow per Share-0.76
Dividends & Yields
Third Harmonic Bio, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.09
52-Week Price Change-62.21%
50-Day Moving Average4.77
200-Day Moving Average8.44
Relative Strength Index (RSI)78.15
Average Volume (3m)295.70K
Important Dates
Third Harmonic Bio, Inc. upcoming earnings date is Aug 7, 2025, TBA Not Confirmed.
Last Earnings DateMay 8, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend Date―
Financial Position
Third Harmonic Bio, Inc. as a current ratio of 40.87, with Debt / Equity ratio of 1.13%
Current Ratio40.87
Quick Ratio40.87
Debt to Market Cap<0.01
Net Debt to EBITDA-4.79
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Third Harmonic Bio, Inc. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Third Harmonic Bio, Inc. EV to EBITDA ratio is 2.51, with an EV/FCF ratio of -4.28.
EV to Sales0.00
EV to EBITDA2.51
EV to Free Cash Flow-4.28
EV to Operating Cash Flow-4.28
Balance Sheet
Third Harmonic Bio, Inc. has $285.06M in cash and marketable securities with $3.21M in debt, giving a net cash position of -$281.86M billion.
Cash & Marketable Securities$285.06M
Total Debt$3.21M
Net Cash-$281.86M
Net Cash Per Share-$6.25
Tangible Book Value Per Share$6.83
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Third Harmonic Bio, Inc. is $5.23, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$5.23
Price Target Upside-1.13% Downside
Analyst ConsensusHold
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast-14.76%